Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy

Affiliations

Comment

Lihteh Wu et al. Am J Ophthalmol. 2021 Feb.

. 2021 Feb:222:397.

doi: 10.1016/j.ajo.2020.09.052. Epub 2020 Nov 10.

No abstract available

Comment on

Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial.
van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Dijkman G, Peters PJH, Tsonaka R, MacLaren RE, Downes SM, Fauser S, Boon CJF, Hoyng CB. van Rijssen TJ, et al. Am J Ophthalmol. 2020 Aug;216:80-89. doi: 10.1016/j.ajo.2020.04.007. Epub 2020 Apr 11. Am J Ophthalmol. 2020. PMID: 32289294 Clinical Trial.
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy.
van Rijssen TJ, van Dijk EHC, Dijkman G, Tsonaka R, Scholz P, Breukink MB, Hoyng CB, Peters PJH, MacLaren RE, Downes SM, Fauser S, Boon CJF. van Rijssen TJ, et al. Am J Ophthalmol. 2021 Feb;222:397-398. doi: 10.1016/j.ajo.2020.10.005. Epub 2020 Nov 12. Am J Ophthalmol. 2021. PMID: 33188739 No abstract available.